4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)-benzenamine
CAS : 56158-10-2
Ref. 3D-GCA15810
25mg | 288,00 € | ||
250mg | 1.081,00 € |
Informations sur le produit
4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)benzenamine is a pandemic influenza drug that has been shown to have antiviral activity against the H1N1 virus. Covid-19, the active ingredient in 4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)benzenamine, is a nucleoside analog that inhibits viral replication by blocking the interaction between viral RNA polymerase and host cell ribosomes. Covid-19 has been shown to be effective against laboratory strains of H1N1 and H3N2 influenza A viruses and is currently undergoing clinical trials. Covid-19 also has antiviral activity against other respiratory viruses such as SARS coronavirus and human metapneumovirus.
Propriétés chimiques
Question d’ordre technique sur : 3D-GCA15810 4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)-benzenamine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages